Vimarsana
Biggest News Aggregation in the World

Page 3 - Cell Rep News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Rep. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Rep Today - Breaking & Trending Today

Co-transplantation of autologous Treg cells in a cell therapy for Parkinson's disease - Vimarsana News

Co-transplantation of autologous Treg cells in a cell therapy for Parkinson's disease

The specific loss of midbrain dopamine neurons (mDANs) causes major motor dysfunction in Parkinson’s disease, which makes cell replacement a promising therapeutic approach1–4. However, poor survival of grafted mDANs remains an obstacle to successful clinical outcomes5–8. Here we show that the surgical procedure itself (referred to here as ‘needle trauma’) triggers a profound host response that is characterized by acute neuroinflammation, robust infiltration of peripheral immune cells and brain cell death. When midbrain dopamine (mDA) cells derived from human induc...

Source: nature.com
Study reveals link between obesity and oral cancer - Vimarsana News

Study reveals link between obesity and oral cancer

A study in mice has linked obesity with dampened immune detection of oral cancers.

New data on Helsinn's oncology pipeline presented at American Society of Clinical Oncology (ASCO) Annual Meeting 2022 - Vimarsana News

New data on Helsinn's oncology pipeline presented at American Society of Clinical Oncology (ASCO) Annual Meeting 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Helsinn Healthcare S.A.: Helsinn to present data at upcoming AMMF's 2022 European Cholangiocarcinoma Conference - Vimarsana News

Helsinn Healthcare S.A.: Helsinn to present data at upcoming AMMF's 2022 European Cholangiocarcinoma Conference

Helsinn to present data at upcoming AMMF's 2022 European Cholangiocarcinoma Conference Lugano, Switzerland, May 11, 2022 - Helsinn Group ("Helsinn"), a fully integrated, global biopharma company

Frontiers | GPX7 Is Targeted by miR-29b and GPX7 Knockdown Enhances Ferroptosis Induced by Erastin in Glioma - Vimarsana News

Frontiers | GPX7 Is Targeted by miR-29b and GPX7 Knockdown Enhances Ferroptosis Induced by Erastin in Glioma

Background Glioma is a lethal primary tumor of central nervous system. Ferroptosis is a newly identified form of necrotic cell death. Triggering ferroptosis has shown potential to eliminate aggressive tumors. GPX7, a member of glutathione peroxidase family (GPXs), has been described to participate in oxidative stress and tumorigenesis. However, the biological functions of GPX7 in glioma are still unknown. Methods Bioinformatics method was used to assess the prognostic role of GPX7 in glioma. CCK8, wound healing, transwell and cell apoptosis assays were performed to explore the functions of GPX...